Unique effects of clozapine: a pharmacological perspective
JY Khokhar, AM Henricks, EDK Sullivan… - Advances in …, 2018 - Elsevier
Schizophrenia is a heterogenous and severe neuropsychiatric disorder that affects nearly
1% of the population worldwide. Antipsychotic drugs are the mainstay of treatment, but not …
1% of the population worldwide. Antipsychotic drugs are the mainstay of treatment, but not …
Clozapine: balancing safety with superior antipsychotic efficacy
HY Meltzer - Clinical schizophrenia & related psychoses, 2012 - meridian.allenpress.com
Clozapine is often referred to as the gold standard for the treatment of schizophrenia and yet
has also been described as the most underutilized treatment for schizophrenia supported by …
has also been described as the most underutilized treatment for schizophrenia supported by …
Clozapine: a review of its pharmacological properties and therapeutic use in patients with schizophrenia who are unresponsive to or intolerant of classical …
AJ Wagstaff, HM Bryson - CNS drugs, 1995 - Springer
Synopsis Clozapine is an atypical antipsychotic agent whose mode of action is thought to
pertain to its interactions with dopamine and serotonin (5-hydroxytryptamine) …
pertain to its interactions with dopamine and serotonin (5-hydroxytryptamine) …
Focus on clozapine
M Naheed, B Green - Current medical research and opinion, 2001 - Taylor & Francis
Clozapine is a dibenzodiazepine derivative and a truly atypical anti-psychotic. Its therapeutic
effects are probably mediated by dopaminergic and serotonergic activity. Although it …
effects are probably mediated by dopaminergic and serotonergic activity. Although it …
Update on the clinical efficacy and side effects of clozapine
A Safferman, JA Lieberman, JM Kane… - Schizophrenia …, 1991 - academic.oup.com
Clozapine (CLOZ) is an atypical antipsychotic drug being used with increasing frequency
throughout the world and has recently been commercially marketed in the United States. Its …
throughout the world and has recently been commercially marketed in the United States. Its …
[HTML][HTML] Clozapine as a model for antipsychotic development
FC Nucifora Jr, M Mihaljevic, BJ Lee, A Sawa - Neurotherapeutics, 2017 - Elsevier
Schizophrenia is a devastating illness that affects up to 1% of the population; it is
characterized by a combination of positive symptoms, negative symptoms, and cognitive …
characterized by a combination of positive symptoms, negative symptoms, and cognitive …
Clozapine: efficacy and safety
RW Buchanan - Schizophrenia bulletin, 1995 - academic.oup.com
Clozapine (Clozaril) represents the first major advance in the pharmacological treatment of
schizophrenia since the introduction of antipsychotics into clinical practice in the 1950s …
schizophrenia since the introduction of antipsychotics into clinical practice in the 1950s …
Clozapine: a review of its pharmacological properties, and therapeutic use in schizophrenia
A Fitton, RC Heel - Drugs, 1990 - Springer
Synopsis Clozapine, an antipsychotic agent of the dibenzodiazepine class, is characterised
by relatively weak central dopaminergic activity and displays atypical pharmacological and …
by relatively weak central dopaminergic activity and displays atypical pharmacological and …
A historical perspective of clozapine
H Hippius - Journal of Clinical Psychiatry, 1999 - psychiatrist.com
Having challenged the established view that extrapyramidal symptoms are an intrinsic
feature of antipsychotic activity, clozapine was developed as the first atypical antipsychotic …
feature of antipsychotic activity, clozapine was developed as the first atypical antipsychotic …
Clozapine: guidelines for clinical management.
JA Lieberman, JM Kane, CA Johns - The Journal of clinical …, 1989 - europepmc.org
The advent of antipsychotic drugs represented a milestone in psychotherapeutics. Despite
their proven efficacy, antipsychotic drugs are limited by side effects and treatment resistance …
their proven efficacy, antipsychotic drugs are limited by side effects and treatment resistance …